Tizanidine
Product Images NDC 50090-2208

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Tizanidine (NDC 50090-2208). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by A-s Medication Solutions, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Tizanidine-1 (Tizanidine 1)

Chemical structure of the active ingredient Tizanidine, showing its molecular framework including chlorine, sulfur, and nitrogen atoms, along with a hydrochloride (HCl) group.*

FDA Label Image

Tizanidine-2 (Tizanidine 2)

A pharmacokinetic line graph showing plasma tizanidine concentration (ng/mL) over time (hours) from dosing. The chart compares four conditions: 4 mg tizanidine tablets with food, tablets without food, capsules with food, and capsules without food, illustrating their concentration changes over a 24-hour period.*

FDA Label Image

Tizanidine-3 (Tizanidine 3)

A line graph depicting improvement in Ashworth Score over 6 hours post-dose for Tizanidine at 8 mg and 16 mg doses, compared to placebo. The vertical axis shows improvement scores, and the horizontal axis represents hours after dosing. Error bars indicate variability in the data.*

FDA Label Image

Tizanidine-4 (Tizanidine 4)

A line graph comparing improvement in Ashworth Score between tizanidine (mean dose 28.8 mg) and placebo over three study timepoints: End of Titration (Week 3), End of Maintenance (Week 7), and Endpoint (Last Observation Carried Forward). The y-axis displays improvement scores, with tizanidine showing greater improvement compared to placebo, including error bars for variability at each timepoint.*

FDA Label Image

Label Image (Lbl500902208)

Tizanidine 4 mg tablet bottle label from A-S Medication Solutions. The label indicates the lot number and specifies that each tablet contains 4.576 mg tizanidine HCl, equivalent to 4 mg tizanidine. Storage instructions state to keep at 77 degrees Fahrenheit. The bottle contains 120 tablets.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.